Home Elon Musk’s Neuralink faces problem with its tiny wires in brain

Elon Musk’s Neuralink faces problem with its tiny wires in brain


  • Neuralink reportedly acknowledges retraction of wires in first patient's brain.
  • Despite wire thinness, they translate brain signals for actions.
  • U.S. FDA aware of issue; Neuralink conducted further animal testing before receiving approval to start human trials.

Neuralink announced last week that the tiny wires inside the brain of its first patient had retracted, but sources say they had known about this issue for years.

According to Reuters, the Elon Musk-founded company knew from animal testing that the wires could pull out of position, removing with them the sensitive electrodes that decode brain signals. Sources told Reuters the risk was deemed low enough for a redesign not to be merited.

Neuralink is an American neurotechnology company currently testing its brain implant in a person with quadriplegia with the hope they’ll be able to use digital devices by thinking alone.

On May 8, an update was provided as Noland Arbaugh, the study participant, had reached over 100 days since he received the Neuralink implant.

“In the weeks following the surgery, a number of threads retracted from the brain, resulting in a net decrease in the number of effective electrodes,” said the team behind the study.

Although the wires are thinner than a human hair, they measure brain signals that are then translated into actions like moving the cursor on a computer screen.

The company says they have since “modified the recording algorithm to be more sensitive to neural population signals” and “improved the techniques to translate these signals into cursor movements, and enhanced the user interface.”

Despite the hiccup, the refinements are said to have produced “a rapid and sustained improvement in BPS, that has now superseded Nolan’s initial performance.”

Sources say Neuralink was aware of the thread issue

The U.S. Food and Drug Administration also knew about the potential issue as the company shared the animal testing results as part of its application to begin human trials, one source said.

While the FDA declined to comment, it told Reuters to continue monitoring the safety of patients enrolled in the company’s study.

When Neuralink first applied to begin human trials, the FDA rejected the initial application and raised concerns around the threads.

More animal testing to address those concerns was carried out which then led to the FDA granting the company approval to begin testing.

Featured Image: Via Ideogram

About ReadWrite’s Editorial Process

The ReadWrite Editorial policy involves closely monitoring the tech industry for major developments, new product launches, AI breakthroughs, video game releases and other newsworthy events. Editors assign relevant stories to staff writers or freelance contributors with expertise in each particular topic area. Before publication, articles go through a rigorous round of editing for accuracy, clarity, and to ensure adherence to ReadWrite's style guidelines.

Sophie Atkinson
Tech Journalist

Sophie Atkinson is a UK-based journalist and content writer, as well as a founder of a content agency which focuses on storytelling through social media marketing. She kicked off her career with a Print Futures Award which champions young talent working in print, paper and publishing. Heading straight into a regional newsroom, after graduating with a BA (Hons) degree in Journalism, Sophie started by working for Reach PLC. Now, with five years experience in journalism and many more in content marketing, Sophie works as a freelance writer and marketer. Her areas of specialty span a wide range, including technology, business,…

Get the biggest tech headlines of the day delivered to your inbox

    By signing up, you agree to our Terms and Privacy Policy. Unsubscribe anytime.

    Tech News

    Explore the latest in tech with our Tech News. We cut through the noise for concise, relevant updates, keeping you informed about the rapidly evolving tech landscape with curated content that separates signal from noise.

    In-Depth Tech Stories

    Explore tech impact in In-Depth Stories. Narrative data journalism offers comprehensive analyses, revealing stories behind data. Understand industry trends for a deeper perspective on tech's intricate relationships with society.

    Expert Reviews

    Empower decisions with Expert Reviews, merging industry expertise and insightful analysis. Delve into tech intricacies, get the best deals, and stay ahead with our trustworthy guide to navigating the ever-changing tech market.